Cyanotech
This article was originally published in The Tan Sheet
Executive Summary
Hawaii-based firm initiates double-blind, placebo-controlled trial to measure effectiveness of BioAstin microalgae supplement in reducing LDL cholesterol while increasing HDL cholesterol. Study also will test whether product can beneficially alter other serum markers. Coordinated by Gene Spiller, PhD, trial will include 44 patients from the Health Research Studies Center in Los Altos, Calif., and is co-sponsored by Cyanotech's marketing partner in Japan, Kyowa Engineering Company
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning